Lexology January 4, 2024
Last year, both Congress and the Biden-Harris administration noticeably increased their attention on Artificial Intelligence (AI). Key congressional committees explored AI implications for health care & life sciences, and the U.S. Department of Health and Human Services (HHS) and its agencies advanced their own initiatives and as part of the federal government’s efforts to implement President Biden’s AI executive order (EO).
On Capitol Hill, much of the AI push thus far has been led by the Senate, where in December the “Group of Four,” comprised of Majority Leader Chuck Schumer (D-NY) and Sens. Martin Heinrich (D-NM), Todd Young (R-IN) and Mike Rounds (R-SD), concluded a months-long series of nine AI Insight Forums on various topics. Notably, the fourth forum, which...
Today's Sponsors
Today's Sponsor